
Results
11
Companies which are more than 50% undervalued based on analyst price target.
11 companies
Prosus
Market Cap: €90.8b
Engages in the e-commerce and internet businesses in Asia, Europe, Latin America, North America, and internationally.
PRX
€39.30
7D
-2.1%
1Y
-15.8%
Adyen
Market Cap: €26.1b
Operates a payments platform in Europe, the Middle East, Africa, North America, the Asia Pacific, and Latin America.
ADYEN
€828.40
7D
1.3%
1Y
-50.0%
Heineken Holding
Market Cap: €17.4b
Engages in brewing and selling beer and cider in the Netherlands, Europe, the Americas, Africa & Middle East, Asia Pacific and internationally.
HEIO
€64.15
7D
5.2%
1Y
-5.0%
CSG
Market Cap: €14.5b
Manufactures and sells defence products in the Czech Republic, Europe, the United States, and the Asia Pacific.
CSG
€14.49
7D
-2.7%
1Y
n/a
Wolters Kluwer
Market Cap: €13.7b
Provides information, software solutions, and services for professionals in the Netherlands, rest of Europe, the United States, Canada, the Asia Pacific, and internationally.
WKL
€61.10
7D
-3.7%
1Y
-58.3%
Exor
Market Cap: €13.5b
Engages in the automotive, agriculture and construction, sports car, commercial vehicle, health technology, football and powertrain businesses in the Netherlands and internationally.
EXO
€66.90
7D
1.8%
1Y
-17.4%
Pharming Group
Market Cap: €787.1m
A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.
PHARM
€1.11
7D
-0.3%
1Y
15.3%
Envipco Holding
Market Cap: €267.7m
Develops, manufactures, assembles, leases, sells, markets, and services a line of reverse vending machines (RVMs) in the Netherlands, the United States, North America, and Europe.
ENVI
€4.05
7D
-7.4%
1Y
-35.5%
Avantium
Market Cap: €196.6m
A chemical technology company, develops and commercializes bio-based plastics and chemicals in the Netherlands.
AVTX
€7.80
7D
-11.6%
1Y
-40.9%
Cabka
Market Cap: €49.4m
Manufactures and sells pallets and large containers made from recycled plastic in Europe, North America, and internationally.
CABKA
€2.00
7D
-1.0%
1Y
0.8%
Vivoryon Therapeutics
Market Cap: €34.1m
Operates as a clinical stage biopharmaceutical company that focuses on research, development, and commercialize small molecule-based medicines.
VVY
€1.15
7D
-7.3%
1Y
-30.0%